Clinical Trial Update: A Study of IBI363 in Subjects With Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for IBI363 in advanced melanoma; study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• IBI363

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Melanoma | Phase 2 | Status: RECRUITING